Guardant Health, Inc.
HealthcareNASDAQ:GH · NASDAQ Global Select
+$0.72 today
Vol 1.45M · Avg 2.19M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $989.3M |
| Short-term Investments | $113.5M |
| Receivables | $137.4M |
| Inventory | $83.9M |
| Other Current | $43.5M |
| Total Current Assets | $1.4B |
| PP&E (Net) | $303.9M |
| Goodwill | $77.3M |
| Intangible Assets | $25.5M |
| Other Non-current | $141.0M |
| Total Non-current Assets | $547.8M |
| Total Assets | $1.9B |
Analysis
Selected assets total $1.9B for Latest. The largest visible component is Cash & Equivalents at $989.3M, about 51.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $378.2M -28.0% | $525.5M -53.6% | $1.1B +700.3% | $141.6M -71.2% | $492.2M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $823.4M +161.9% | $314.4M +795.9% | $35.1M -96.0% | $869.6M +97.4% | $440.5M | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $137.8M +25.0% | $110.3M +24.2% | $88.8M -8.7% | $97.3M -0.4% | $97.7M | $533.8M | $399.4M | -$1.7B |
| Inventory | $85.9M +20.8% | $71.1M +14.7% | $61.9M +20.1% | $51.6M +68.2% | $30.7M | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $40.7M +20.5% | $33.8M +21.8% | $27.7M -12.0% | $31.5M | $0 | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $1.5B +38.9% | $1.1B -21.7% | $1.3B +13.1% | $1.2B +7.0% | $1.1B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $304.8M +9.2% | $279.1M -7.8% | $302.7M -11.5% | $341.9M +8.9% | $313.9M | $1.2B | $1.5B | $687.8M |
| Goodwill | $77.3M +2248.2% | $3.3M +0.0% | $3.3M +0.0% | $3.3M +0.0% | $3.3M | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $25.9M +283.4% | $6.8M -24.7% | $9.0M -23.4% | $11.7M -17.5% | $14.2M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $0 | $0 | $0 | $0 -100.0% | $698.0M | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $139.7M -1.2% | $141.4M +13.7% | $124.3M +102.3% | $61.5M +0.8% | $60.9M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $547.6M +27.2% | $430.5M -2.0% | $439.3M +5.0% | $418.4M -61.6% | $1.1B | -$15.3B | $14.8B | $11.3B |
| Total Assets | $2.0B +35.5% | $1.5B -16.8% | $1.8B +11.0% | $1.6B -27.0% | $2.2B | $13.3B | $11.9B | $10.6B |
| Account Payables | $54.4M +41.2% | $38.6M -25.5% | $51.7M -24.9% | $68.9M +78.9% | $38.5M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $0 -100.0% | $29.2M | $0 | $0 | $0 | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 -100.0% | $4.2M | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $50.8M +43.1% | $35.5M +97.4% | $18.0M +3.2% | $17.4M +53.7% | $11.3M | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $197.5M +404.8% | $39.1M -46.2% | $72.7M +30.4% | $55.8M -53.7% | $120.5M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $302.7M +34.2% | $225.6M +9.6% | $205.9M +6.6% | $193.2M -0.8% | $194.7M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $1.7B +47.3% | $1.1B +0.2% | $1.1B +0.2% | $1.1B +0.2% | $1.1B | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $127.8M +37.6% | $92.8M -3.3% | $96.0M +945.9% | $9.2M +133.4% | $3.9M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $1.8B +29.3% | $1.4B -1.6% | $1.4B +4.8% | $1.4B -0.6% | $1.4B | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $2.1B +30.0% | $1.6B -0.2% | $1.6B +5.0% | $1.5B -0.6% | $1.6B | $14.7B | $3.7B | $9.6B |
| Common Stock | $1.0K +0.0% | $1.0K +0.0% | $1.0K +0.0% | $1.0K +0.0% | $1.0K | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$3.0B -16.1% | -$2.6B -20.4% | -$2.1B -28.8% | -$1.7B -65.0% | -$1.0B | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | -$4.9M +6.7% | -$5.2M -41.5% | -$3.7M +81.2% | -$19.5M -309.8% | -$4.8M | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | -$99.3M +28.9% | -$139.6M -188.0% | $158.7M +163.7% | $60.2M -90.7% | $645.0M | $9.1B | $7.7B | $3.3B |
| Total Debt | $1.7B +25.9% | $1.3B -1.3% | $1.4B -1.1% | $1.4B -0.3% | $1.4B | $724.2M | $410.6M | $399.4M |
| Net Debt | $1.3B +60.9% | $810.5M +268.0% | $220.2M -82.1% | $1.2B +39.3% | $881.5M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Exact Sciences Corporation
EXAS
$20.03B
Viatris Inc.
NASDAQ:VTRS
$19.19B
Solventum Corporation
NYSE:SOLV
$13.66B
Ascendis Pharma A/S
NASDAQ:ASND
$13.47B
BridgeBio Pharma, Inc.
NASDAQ:BBIO
$13.08B
Ionis Pharmaceuticals, Inc.
NASDAQ:IONS
$12.11B
ICON Public Limited Company
NASDAQ:ICLR
$11.19B
Revvity, Inc.
NYSE:RVTY
$11.12B
Encompass Health Corporation
NYSE:EHC
$10.07B
Qiagen N.V.
NYSE:QGEN
$7.64B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does GH have?
Guardant Health, Inc. (GH) reported $378.20M in cash and equivalents in fiscal 2025.
How much debt does GH carry?
Guardant Health, Inc. (GH) reported $1.68B of total debt, with net debt of $1.30B.
Explore More
Continue the stock analysis
Jump to another research area for this company.